annual CFO:
-$116.59M-$73.81M(-172.54%)Summary
- As of today (June 17, 2025), MLTX annual cash flow from operations is -$116.59 million, with the most recent change of -$73.81 million (-172.54%) on December 31, 2024.
- MLTX annual CFO is now -172.54% below its all-time high of -$42.78 million, reached on December 31, 2023.
Performance
MLTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$38.14M+$10.33M(+21.32%)Summary
- As of today (June 17, 2025), MLTX quarterly cash flow from operations is -$38.14 million, with the most recent change of +$10.33 million (+21.32%) on March 31, 2025.
- Over the past year, MLTX quarterly CFO has dropped by -$23.19 million (-155.15%).
- MLTX quarterly CFO is now -322.63% below its all-time high of -$9.02 million, reached on March 31, 2023.
Performance
MLTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$139.78M-$23.19M(-19.89%)Summary
- As of today (June 17, 2025), MLTX TTM cash flow from operations is -$139.78 million, with the most recent change of -$23.19 million (-19.89%) on March 31, 2025.
- Over the past year, MLTX TTM CFO has dropped by -$91.08 million (-187.01%).
- MLTX TTM CFO is now -885.33% below its all-time high of -$14.19 million, reached on March 31, 2022.
Performance
MLTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MLTX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -172.5% | -155.2% | -187.0% |
| 3 y3 years | - | -168.9% | -885.3% |
| 5 y5 years | - | - | - |
MLTX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -172.5% | at low | -322.6% | +21.3% | -885.3% | at low |
| 5 y | 5-year | -172.5% | at low | -322.6% | +21.3% | -885.3% | at low |
| alltime | all time | -172.5% | at low | -322.6% | +21.3% | -885.3% | at low |
MLTX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$38.14M(-21.3%) | -$139.78M(+19.9%) |
| Dec 2024 | -$116.59M(+172.5%) | -$48.47M(+91.8%) | -$116.59M(+44.9%) |
| Sep 2024 | - | -$25.27M(-9.4%) | -$80.46M(+24.9%) |
| Jun 2024 | - | -$27.89M(+86.6%) | -$64.43M(+32.3%) |
| Mar 2024 | - | -$14.95M(+21.1%) | -$48.70M(+13.8%) |
| Dec 2023 | -$42.78M | -$12.34M(+33.4%) | -$42.78M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$9.25M(-23.9%) | -$42.03M(-0.2%) |
| Jun 2023 | - | -$12.16M(+34.7%) | -$42.13M(-17.0%) |
| Mar 2023 | - | -$9.02M(-22.2%) | -$50.73M(-9.2%) |
| Dec 2022 | -$55.89M | -$11.60M(+24.0%) | -$55.89M(+26.2%) |
| Sep 2022 | - | -$9.35M(-55.0%) | -$44.30M(+26.8%) |
| Jun 2022 | - | -$20.76M(+46.3%) | -$34.95M(+146.3%) |
| Mar 2022 | - | -$14.19M | -$14.19M |
FAQ
- What is MoonLake Immunotherapeutics annual cash flow from operations?
- What is the all time high annual CFO for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CFO year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CFO year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CFO year-on-year change?
What is MoonLake Immunotherapeutics annual cash flow from operations?
The current annual CFO of MLTX is -$116.59M
What is the all time high annual CFO for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash flow from operations is -$42.78M
What is MoonLake Immunotherapeutics annual CFO year-on-year change?
Over the past year, MLTX annual cash flow from operations has changed by -$73.81M (-172.54%)
What is MoonLake Immunotherapeutics quarterly cash flow from operations?
The current quarterly CFO of MLTX is -$38.14M
What is the all time high quarterly CFO for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash flow from operations is -$9.02M
What is MoonLake Immunotherapeutics quarterly CFO year-on-year change?
Over the past year, MLTX quarterly cash flow from operations has changed by -$23.19M (-155.15%)
What is MoonLake Immunotherapeutics TTM cash flow from operations?
The current TTM CFO of MLTX is -$139.78M
What is the all time high TTM CFO for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash flow from operations is -$14.19M
What is MoonLake Immunotherapeutics TTM CFO year-on-year change?
Over the past year, MLTX TTM cash flow from operations has changed by -$91.08M (-187.01%)